Csiky B, Simon G
Department of Medicine, Veterans Affairs Medical Center, Minneapolis, Minnesota, USA.
Am J Physiol. 1997 Sep;273(3 Pt 2):H1275-82. doi: 10.1152/ajpheart.1997.273.3.H1275.
The hypertensinogenic action of dietary sodium supplementation was investigated in angiotensin II (ANG II)-treated rats. We hypothesized that high-sodium diet would potentiate ANG II-induced vasoconstriction and hypertension, including the development of structural vascular changes, through synergistic action with ANG II in stimulating sympathetic activity and vascular growth. Mesenteric vasoconstrictor responses to ANG II, norepinephrine (NE), arginine vasopressin (AVP), and periarterial nerve stimulation were measured in Sprague-Dawley rats after 7-10 days of the following treatments: 200 ng.kg-1.min-1 ip ANG II (n = 12), 4% NaCl diet (n = 11), ANG II + 4% NaCl diet (n = 7), and 0.7% NaCl diet (controls) (n = 15). Additional rats received 50 ng.kg-1.min-1 sc ANG II (n = 8), 2% NaCl diet (n = 9), ANG II + 2% NaCl diet (n = 6), or 0.7% NaCl diet (controls) (n = 10) for 12 wk. Systolic blood pressure (SBP) values were measured weekly for 4 wk and then every other week for 8 wk. Then, the wall-to-lumen ratio (W/L) of mesenteric resistance arteries (< 150 microns OD) was measured after in situ perfusion-fixation. After 7-10 days of treatment, there were no significant changes in SBP in any of the groups. High-sodium diet increased vasoconstrictor responses to ANG II (P < 0.01) and nerve stimulation (P < 0.02), but not to NE or AVP, and in combination with ANG II treatment further potentiated vasoconstrictor responses to ANG II (synergism). After 12 wk of treatment, ANG II increased W/L of small resistance arteries by 11% (P < 0.05) without a significant rise in SBP. ANG II and 2% NaCl diet in combination raised SBP by 36 mmHg (P < 0.01) and increased small artery W/L by 28% (P < 0.001) compared with values obtained in control rats. To test the specificity of the interaction between ANG II and high-sodium diet, all the experiments were repeated during phenylephrine (PE, 10 micrograms.kg-1.min-1 sc) treatment of rats. PE by itself or in combination with high-sodium diet had no effect on the measured parameters. Thus short-term administration of high-sodium diet appears to potentiate vasoconstrictor responses to ANG II by facilitating sympathetic neurotransmission, and long-term administration of high-sodium diet raises SBP by potentiating the trophic vascular effects of ANG II. The interaction appears to be specific to ANG II and is occurring on the vascular level.
在接受血管紧张素II(ANG II)治疗的大鼠中研究了补充膳食钠的致高血压作用。我们假设高钠饮食会通过与ANG II协同刺激交感神经活动和血管生长,增强ANG II诱导的血管收缩和高血压,包括血管结构变化的发展。在进行以下处理7 - 10天后,测量Sprague-Dawley大鼠肠系膜血管对ANG II、去甲肾上腺素(NE)、精氨酸加压素(AVP)和动脉周围神经刺激的血管收缩反应:200 ng·kg-1·min-1腹腔注射ANG II(n = 12)、4% NaCl饮食(n = 11)、ANG II + 4% NaCl饮食(n = 7)以及0.7% NaCl饮食(对照组)(n = 15)。另外的大鼠接受50 ng·kg-1·min-1皮下注射ANG II(n = 8)、2% NaCl饮食(n = 9)、ANG II + 2% NaCl饮食(n = 6)或0.7% NaCl饮食(对照组)(n = 10),持续12周。每周测量收缩压(SBP)值,持续4周,然后每隔一周测量8周。然后,在原位灌注固定后测量肠系膜阻力动脉(外径< 150微米)的壁腔比(W/L)。治疗7 - 10天后,任何组的SBP均无显著变化。高钠饮食增加了对ANG II的血管收缩反应(P < 0.01)和对神经刺激的反应(P < 0.02),但对NE或AVP无影响,并且与ANG II治疗联合进一步增强了对ANG II的血管收缩反应(协同作用)。治疗12周后,ANG II使小阻力动脉的W/L增加了11%(P < 0.05),而SBP没有显著升高。与对照大鼠相比,ANG II和2% NaCl饮食联合使SBP升高了36 mmHg(P < 0.01),并使小动脉W/L增加了28%(P < 0.001)。为了测试ANG II与高钠饮食之间相互作用的特异性,在对大鼠进行去氧肾上腺素(PE,10微克·kg-1·min-1皮下注射)治疗期间重复了所有实验。PE单独使用或与高钠饮食联合使用对所测参数均无影响。因此,短期给予高钠饮食似乎通过促进交感神经传递增强了对ANG II的血管收缩反应,而长期给予高钠饮食通过增强ANG II的血管营养作用升高了SBP。这种相互作用似乎对ANG II具有特异性,并且发生在血管水平。